1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Quality assessment for included studies
Studya Question Total 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Noncontrast studies Alexandrov et al 2 2 2 2 * * * 2 2 2 2 * 2 2 20/20 Daffertshofer et al 2 2 1 2 * * * 2 1 2 2 * 2 2 18/20 Derex et al 2 2 2 2 * * * 1 2 2 2 * 2 2 19/20 Eggers et al 2 2 2 2 2 * * 2 1 2 2 2 2 2 23/24 Gerriets et al (DIAS) 2 2 2 2 * * * 2 2 2 * * 2 2 18/18 Kwon et al 1 1 2 2 * * * 2 1 2 2 * 2 2 17/20 Molina et al 2 2 2 2 * 2 * 2 2 2 2 2 2 2 24/24 Neumann-Haefelin et al 2 2 2 1 * * * 2 1 2 2 * 2 2 18/20 Rubeira et al 2 2 2 2 * * * 2 2 2 2 * 2 2 20/20 Savitz et al 2 2 2 2 * * * 2 2 2 2 * 2 2 20/20 Sekoranja et al 2 2 2 2 * * * 2 1 1 * * 2 2 16/18 Yasaka et al (ASK) 2 2 2 2 2 2 2 2 1 2 2 2 2 2 27/28 Contrast studies Muir et al 2 2 2 2 * 2 * 2 1 2 2 * 2 2 21/22 Murphy et al 2 2 2 2 * 2 * 2 1 2 2 * 2 2 21/22 Wintermark et al 2 2 2 2 * * * 2 2 2 2 * 2 2 20/20 von Kummer et al 2 2 2 2 * * * 2 2 2 2 * 2 2 20/20 Sasaki et al 2 2 2 2 * * * 2 1 2 2 * 2 2 19/20 Mori et al 2 2 2 2 2 2 2 2 1 2 2 * 2 2 25/26
Note:—ASK indicates Australian Streptokinase Trial.
a These are the same studies as cited in Table 1.